reduce - CAS号查询

Benzenesulfonic acid, 2-methyl-5-nitro-, alk. cond. products, reduced, lithium salts;
Benzenesulfonic acid,2-methyl-5-nitro-,alk. cond. products,reduced,lithium salts

无

详情

供应商

91917-63-4

人α-ANF(I-28)

Atrial natriureticpeptide-28 (human reduced) (9CI);
Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-;
13: PN: WO2004089280 SEQID: 13 unclaimed sequence;
13: PN: WO2005103087 SEQID:16 unclaimed sequence;
140: PN: WO2008058016 SEQID: 141 claimed protein;
15:PN: US20030119021 SEQID: 14 unclaimed sequence;
15: PN: WO2008154226 SEQID: 15unclaimed protein;
16: PN: WO0071576 SEQID: 16 unclaimed sequence;
18: PN:WO2004022003 SEQID: 4 claimed sequence;
18: PN: WO2005094420 SEQID: 4 claimedsequence;
19: PN: WO2007034498 SEQID: 18 unclaimed sequence;
1: PN: DE19942230SEQID: 6 claimed protein;
1: PN: US20030069186 SEQID: 5 unclaimed sequence;
1:PN: US20090163421 SEQID: 1 unclaimed sequence;
1: PN: WO0185945 SEQID: 1unclaimed sequence;
2145: PN: WO03060071 SEQID: 2207 unclaimed;
21: PN:WO2004045592 SEQID: 20 unclaimed sequence;
220: PN: US20060293232 PAGE: 14unclaimed sequence;
294: PN: WO0069900 SEQID: 476 unclaimed sequence;
2: PN:GB2403533 SEQID: 2 claimed sequence;
2: PN: WO02074234 FIGURE: 3B claimedprotein;
301: PN: US20080004206 SEQID: 302 unclaimed protein;
313: PN:WO0069900 SEQID: 495 unclaimed sequence;
38: PN: WO2005003296 SEQID: 309unclaimed sequence;
393: PN: US20090175821 SEQID: 476 claimed protein;
3: PN:CN1278007 SEQID: 5 unclaimed sequence;
3: PN: US20080194481 SEQID: 302 claimedprotein;
439: PN: US20080312157 SEQID: 456 unclaimed sequence;
4: PN:US20080214437 SEQID: 4 claimed protein;
4: PN: WO2009073527 SEQID: 4 claimedprotein;
4: PN: WO2009142307 SEQID: 100 claimed protein;
5-32-Urodilatin(human);
59: PN: US6033884 SEQID: 53 unclaimed protein;
5: PN: WO2007035600SEQID: 3 unclaimed sequence;
604: PN: WO2009058322 SEQID: 302 claimed sequence;
78: PN: WO03099862 PAGE: 45 unclaimed protein;
7: PN: US20060183154 SEQID: 7claimed sequence;
95: PN: WO2007047504 SEQID: 179 unclaimed sequence;
99-126-natriuretic hormone peptide (human);
9: PN: US20010027181 SEQID: 1unclaimed protein;
Atriopeptin-28 (Canis familiaris reduced);

Atrial natriureticpeptide-24 (Rana catesbeiana reduced) (9CI);
Atriopeptin-21(rat reduced), 2a-endo-L-aspartic acid-6-L-serine-17-L-methionine-20-glycine-21-L-arginine-21a-L-arginine-21b-L-phenylalanine-;
286: PN: WO0069900 SEQID: 468 unclaimed sequence;
289: PN: WO0069900 SEQID: 471unclaimed sequence;
386: PN: US20090175821 SEQID: 468 claimed protein;
3: PN:US20010027181 SEQID: 5 unclaimed sequence;
L-Phenylalanine, L-seryl-L-seryl-L-a-aspartyl-L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl-L-arginyl-

Atrial natriureticpeptide-29 (chicken reduced) (9CI);
Atriopeptin-29(chicken reduced);
283: PN: WO0069900 SEQID: 465 unclaimed sequence;
383: PN:US20090175821 SEQID: 465 claimed protein;
5: PN: US20010027181 SEQID: 8unclaimed sequence;
L-Asparagine, L-methionyl-L-methionyl-L-arginyl-L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-methionylglycyl-L-cysteinyl-L-asparaginylglycyl-L-seryl-L-arginyl-L-lysyl-;
a-Atriopeptin (chicken reduced)

Atrial natriureticpeptide-25 (human reduced) (9CI);
Atriopeptin-21(rat reduced),N-L-arginyl-8-L-methionine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;
20: PN: WO2007034498 SEQID: 19 unclaimed sequence;
298: PN: WO0069900 SEQID:480 unclaimed sequence;
2: PN: US20070232529 SEQID: 16 unclaimed sequence;
397:PN: US20090175821 SEQID: 480 claimed protein;
8-32-Urodilatin (human);
L-Tyrosine,L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-

Atrial natriureticpeptide-26 (human reduced) (9CI);
Atriopeptin-21(rat reduced),N-(N2-L-arginyl-L-arginyl)-8-L-methionine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;
297: PN: WO0069900 SEQID: 479 unclaimed sequence;
396: PN: US20090175821 SEQID:479 claimed protein;
L 364370;
L-Tyrosine, L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-

a-Conotoxin G II (reduced) (9CI);
ConotoxinG I (reduced), 4-L-histidine-9-L-lysine-11-L-phenylalanine-;
L-Cysteinamide, L-a-glutamyl-L-cysteinyl-L-cysteinyl-L-histidyl-L-prolyl-L-alanyl-L-cysteinylglycyl-L-lysyl-L-histidyl-L-phenylalanyl-L-seryl-

Atrial natriureticpeptide-24 (rat reduced) (9CI);
Atriopeptin-21(rat reduced), 21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;
303: PN:WO0069900 SEQID: 485 unclaimed sequence;
402: PN: US20090175821 SEQID: 485claimed protein;
L-Tyrosine,L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-

Atrial natriureticpeptide-21 (Rana catesbeiana reduced) (9CI);
Atriopeptin-21(rat reduced), 1-de-L-serine-2-de-L-serine-6-L-serine-17-L-methionine-20-glycine-21-L-arginine-21a-L-arginine-21b-L-phenylalanine-;
288: PN: WO0069900 SEQID: 470 unclaimed sequence;
388: PN: US20090175821 SEQID:470 claimed protein;
L-Phenylalanine, L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl-L-arginyl-

Apamin (reduced)(8CI,9CI);
L-Histidinamide,L-cysteinyl-L-asparaginyl-L-cysteinyl-L-lysyl-L-alanyl-L-prolyl-L-a-glutamyl-L-threonyl-L-alanyl-L-leucyl-L-cysteinyl-L-alanyl-L-arginyl-L-arginyl-L-cysteinyl-L-glutaminyl-L-glutaminyl-

无

Adipokinetic hormoneprecursor-related peptide 1 (Schistocerca gregaria reduced) (9CI);
Adipokinetichormone precursor-related peptide 2 (Schistocerca gregaria a-chain reduced);
L-Asparagine, L-a-aspartyl-L-alanyl-L-alanyl-L-a-aspartyl-L-phenylalanylglycyl-L-a-aspartyl-L-prolyl-L-tyrosyl-L-seryl-L-phenylalanyl-L-leucyl-L-tyrosyl-L-arginyl-L-leucyl-L-isoleucyl-L-glutaminyl-L-alanyl-L-a-glutamyl-L-alanyl-L-arginyl-L-lysyl-L-methionyl-L-serylglycyl-L-cysteinyl-L-seryl-;
Protein (Schistocerca gregaria prepro-adipokinetic hormone I C-terminal a-chain)

Atrial natriureticpeptide-21 (rat reduced) (9CI);
Atriopeptin-21(rat reduced);
301: PN: WO0069900 SEQID: 483 unclaimed sequence;
400: PN:US20090175821 SEQID: 483 claimed protein;
L-Serine,L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-

Atrial natriureticpeptide-28 (rat reduced) (9CI);
Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-;
10: PN: US20010027181 SEQID: 2 unclaimed sequence;
26: PN: US20070049521 SEQID:26 claimed sequence;
304: PN: WO0069900 SEQID: 486 unclaimed sequence;
3: PN:WO2004056970 TABLE: 1 unclaimed sequence;
403: PN: US20090175821 SEQID: 486claimed protein;
7: PN: WO2008036970 FIGURE: 2 unclaimed sequence;
Atrialnatriuretic peptide (6-33);
Atriopeptin-28 (rabbit reduced);
Cardionatrin I(rat reduced);
L-Tyrosine,L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-

a-Conotoxin Pn IA (reduced) (9CI);
L-Cysteinamide,glycyl-L-cysteinyl-L-cysteinyl-L-seryl-L-leucyl-L-prolyl-L-prolyl-L-cysteinyl-L-alanyl-L-alanyl-L-asparaginyl-L-asparaginyl-L-prolyl-L-a-aspartyl-O-sulfo-L-tyrosyl-

Atrial natriureticpeptide-24 (human reduced) (9CI);
Atriopeptin-21(rat reduced),8-L-methionine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;
21: PN:WO2007034498 SEQID: 20 unclaimed sequence;
291: PN: WO0069900 SEQID: 473unclaimed sequence;
390: PN: US20090175821 SEQID: 473 claimed protein;
L-Tyrosine, L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-

Brain natriureticpeptide-26 (swine reduced) (9CI);
Natriureticfactor-26 (pig brain reduced);
329: PN: WO0069900 SEQID: 511 unclaimedsequence;
424: PN: US20090175821 SEQID: 511 claimed protein;
8: PN:WO2008036970 FIGURE: 2 unclaimed sequence;
L-Tyrosine, L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-leucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-valyl-L-leucyl-L-arginyl-L-arginyl-;
Porcine brain natriuretic peptide

Bombyxin IV (B-chainreduced) (9CI);
Bombyxin IV(silkworm gene E1 B-chain reduced);
L-Glutamic acid, 5-oxo-L-prolyl-L-a-glutamyl-L-alanyl-L-asparaginyl-L-valyl-L-alanyl-L-histidyl-L-histidyl-L-tyrosyl-L-cysteinylglycyl-L-arginyl-L-histidyl-L-leucyl-L-alanyl-L-asparaginyl-L-threonyl-L-leucyl-L-alanyl-L-a-aspartyl-L-leucyl-L-cysteinyl-L-tryptophyl-L-a-aspartyl-L-threonyl-L-seryl-L-valyl-

Bombyxin IV (A-chainreduced) (9CI);
24: PN:JP2000191697 PAGE: 6 unclaimed sequence;
Bombyxin IV (silkworm gene E1 A-chainreduced);
L-Cysteine, glycyl-L-valyl-L-valyl-L-a-aspartyl-L-a-glutamyl-L-cysteinyl-L-cysteinyl-L-isoleucyl-L-glutaminyl-L-prolyl-L-cysteinyl-L-threonyl-L-leucyl-L-a-aspartyl-L-valyl-L-leucyl-L-alanyl-L-threonyl-L-tyrosyl-

C90H145N21O31S4

详情

供应商

化工产品